Pituitary suppression regimens in poor responders undergoing IVF treatment: a systematic review and meta-analysis (Q33306633)

25 July 2017

0 references

1 reference

title

Pituitary suppression regimens in poor responders undergoing IVF treatment: a systematic review and meta-analysis (English)

1 reference

25 July 2017

1 reference

Arri Coomarasamy

1 reference

25 July 2017

Sesh Kamal Sunkara

1 reference

25 July 2017

Josephine Tuthill

1 reference

25 July 2017

Mohammed Khairy

1 reference

25 July 2017

Tarek El-Toukhy

1 reference

25 July 2017

Yakoub Khalaf

1 reference

25 July 2017

Peter Braude

1 reference

25 July 2017

publication date

1 November 2007

1 reference

Reproductive BioMedicine Online

25 July 2017

published in

1 reference

25 July 2017

1 reference

25 July 2017

1 reference

25 July 2017

page(s)

539-546

1 reference

Comparison of agonistic flare-up-protocol and antagonistic multiple dose protocol in ovarian stimulation of poor responders: results of a prospective randomized trial

25 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960386-0

7 January 2021

Addition of GnRH antagonist in cycles of poor responders undergoing IVF.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960386-0

7 January 2021

GnRH antagonist versus long GnRH agonist protocol in poor responders undergoing IVF: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960386-0

7 January 2021

Gonadotropin-releasing hormone agonist use in assisted reproduction cycles: the influence of long and short regimens on pregnancy rates

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960386-0

7 January 2021

Gonadotropin-releasing hormone (GnRH) antagonist plus recombinant luteinizing hormone vs. a standard GnRH agonist short protocol in patients at risk for poor ovarian response

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960386-0

7 January 2021

Cessation of gonadotropin-releasing hormone analogue (GnRH-a) upon down-regulation versus conventional long GnRH-a protocol in poor responders undergoing in vitro fertilization

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960386-0

7 January 2021

Cessation of gonadotropin-releasing hormone agonist therapy combined with high-dose gonadotropin stimulation yields favorable pregnancy results in low responders

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960386-0

7 January 2021

Follicular phase gonadotropin-releasing hormone agonist and human gonadotropins: a better alternative for ovulation induction in in vitro fertilization

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960386-0

7 January 2021

High doses of gonadotrophins combined with stop versus non-stop protocol of GnRH analogue administration in low responder IVF patients: a prospective, randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960386-0

7 January 2021

Gonadotropin-releasing hormone antagonists for assisted reproductive techniques: are there clinical differences between agents?

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960386-0

7 January 2021

Revisiting gonadotrophin-releasing hormone agonist protocols and management of poor ovarian responses to gonadotrophins

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960386-0

7 January 2021

Assisted conception following poor ovarian response to gonadotrophin stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960386-0

7 January 2021

Medical hypophysectomy: I. Dose-response using a gonadotropin-releasing hormone antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960386-0

7 January 2021

Hormonal responses to the new potent GnRH antagonist Cetrorelix

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960386-0

7 January 2021

Management of poor responders in IVF

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960386-0

7 January 2021

Poor responders: does the protocol make a difference?

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960386-0

7 January 2021

Comparison of a gonadotropin-releasing hormone (GnRH) antagonist and GnRH agonist flare-up regimen in poor responders undergoing ovarian stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960386-0

7 January 2021

GnRH antagonist in IVF poor-responder patients: results of a randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960386-0

7 January 2021

A controlled trial of natural cycle versus microdose gonadotropin-releasing hormone analog flare cycles in poor responders undergoing in vitro fertilization

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960386-0

7 January 2021

A randomized prospective study of microdose leuprolide versus ganirelix in in vitro fertilization cycles for poor responders

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960386-0

7 January 2021

Interventions for 'poor responders' to controlled ovarian hyperstimulation (COH) in in-vitro fertilisation (IVF)

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960386-0

7 January 2021

Evaluating strategies for improving ovarian response of the poor responder undergoing assisted reproductive techniques

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960386-0

7 January 2021

Prospective evaluation of two stimulation protocols for low responders who were undergoing in vitro fertilization–embryo transfer

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960386-0

7 January 2021

10.1016/S1472-6483(10)60386-0

Identifiers

DOI

1 reference

25 July 2017

1 reference